Bachem Holding Competitors and Similar CompaniesClear all

Bachem Holding's competitors and similar companies include Catalent.
Bachem Holding
Bachem Holding
Bachem Holding is a company that manufactures ingredients for pharmaceuticals, generic drugs, and research supplies.
Catalent
Catalent
Catalent is a company that develops and manufactures solutions for drugs, protein-based biologics, cell and gene therapies, vaccines, and consumer health products.
Founding Date
Founding Date
1971
Founding Date
2007
Type
Type
Public
Type
Subsidiary
Tags
Locations
Locations
Bubendorf, CH HQ
Tokyo, JP
Torrance, US
Locations
Bridgewater, US HQ
Buenos Aires, AR
Bruxelles, BE
Charleroi, BE
Charleroi, BE
Charleroi, BE
Indaiatuba, BR
see more
Employees
Employees
2,207
Employees
12,6955% increase

Financial

Revenue (est.)
Revenue (est.)
CHF695.1m (FY, 2025)
Revenue (est.)
$4.4b (FY, 2024)
Cost of goods
Cost of goods
CHF447.9m (FY, 2025)
Cost of goods
$3.4b (FY, 2024)
Gross profit
Gross profit
CHF264.2m (FY, 2025)
Gross profit
$953m (FY, 2024)
Net income
Net income
CHF148.8m (FY, 2025)
Net income
($1b) (FY, 2024)
For sources of this data, please see the company profile

View Company Profiles

Catalent
HQ
Bridgewater, US

Catalent is a company that develops and manufactures solutions for drugs, protein-based biologics, cell and gene therapies, vaccines, and consumer health products.

View company